Alastair Greystoke - Newcastle University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 232 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract CT279: DareonTM-5: An open-label phase 2 trial of BI 764532, a DLL3-targeting T-cell engager, in patients (pts) with relapsed/refractory small cell lung cancer or other neuroendocrine carcinomas

Valentina Gambardella,Alastair Greystoke,Martin Reck,Meiruo Liu,Martha Mueller, Ulrich Duenzinger,Emily B. Bergsland,Taofeek Owonikoko

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Canakinumab Versus Placebo in Combination with First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results from the CANOPY-1 Trial

JOURNAL OF CLINICAL ONCOLOGYno. 2 (2024)

引用0浏览0WOS引用

Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis

Carlo Messina,Emilio Francesco Giunta,Alessio Signori,Sara Elena Rebuzzi,Giuseppe Luigi Banna,Akash Maniam,Sebastiano Buti,Carlo Cattrini,Giuseppe Fornarini,Matteo Bauckneht,Alastair Greystoke,Ruth Plummer,Christoph Oing,Pasquale Rescigno

EUROPEAN UROLOGY ONCOLOGY（2024）

引用3浏览0WOS引用

119 Estimating the Health Benefits of Introducing Ctdna Next Generation Sequencing to the Diagnostic Pathway for Advanced Lung Cancer: A Modelling Study

Neal Navani, Alexander van Doornewaard, Verena Schneider, Marson Phoebe Smith,Riyaz Shah,Alastair Greystoke,Matthew Krebs,Sophie Scott,Iris Faull,Elisabeth Adams,Sanjay Popat

LUNG CANCER (2024)

引用0浏览0引用

Social Determinants of Health Inequalities in Early Phase Clinical Trials in Northern England

S. Rae, S. Shaya, E. Taylor, J. Hoben, D. Oluwashegun, H. Lowe,N. Haris,S. Bashir,C. Oing,M. G. Krebs,F. C. Thistlethwaite,L. Carter,N. Cook,A. Greystoke,D. M. Graham,R. Plummer

BRITISH JOURNAL OF CANCERno. 4 (2024): 685-691

引用0浏览0WOSNATURE引用

A Gut Microbiota Rheostat Forecasts Responsiveness to PD-L1 and VEGF Blockade in Mesothelioma

NATURE COMMUNICATIONSno. 1 (2024)

引用0浏览0WOSNATURE引用

77P Experience Pooling Control Arms Within a Complex Phase I Drug-Radiotherapy (RT) Platform Trial

Jamie B. Oughton, J. Kendall, R.H. Phillip,Mark A. Norris,Ashley Horne, O.A. Ojo,Alastair Greystoke,Corinne Faivre‐Finn, F. Walker,P.H. Shaw,K. Franks,Stephen Harrow,Crispin T. Hiley,Anthony J. Chalmers, Stanley B. Brown

ESMO open (2024): 102305-102305

引用0浏览0引用

220 Patient with T1N3M1 (liver) Non-Squamous NSCLC Diagnosed July 2008. Subsequently Confirmed EXON 18 EGFR Mutation (2016) - Durable Survival, Late Effects: Learning from Our Patient's Experiences over a 16 Year Period (2008 to the Present)

Paula Mulvenna, Matthew Anderson, Margaret Peel, Christine Ruahton, Sally Hall, Jill Gardiner,Greystoke Alastair, Damian Holliman,Priya Bhatnagar

Lung Cancer (2024): 107781

引用0浏览0引用

Abstract CT101: Final Results of the First-in-human Study of the Porcupine (PORCN) Inhibitor Zamaporvint (RXC004) in Patients with Advanced Solid Tumors

Natalie Cook,Sarah Blagden,Juanita Lopez,Debashis Sarker,Alastair Greystoke,Noor MD Haris,Farasat Kazmi,Kaiser Anam, Ana Ortego Franco,Rille Pihlak,Louise Goodwin, David Wilson,Caroline Phillips,Jane Robertson, Helen Timmis,Craig Tilston,Simon A. Woodcock,Ruth Plummer

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Advancing Patient-Centric Care: Integrating Patient Reported Outcomes for Tolerability Assessment in Early Phase Clinical Trials – Insights from an Expert Virtual Roundtable

Christina Yap,Olalekan Lee Aiyegbusi,Emily Alger,Ethan Basch,Jill Bell,Vishal Bhatnagar,David Cella,Philip Collis,Amylou C. Dueck,Alexandra Gilbert,Ari Gnanasakthy,Alastair Greystoke,Aaron R. Hansen,Paul Kamudoni,Olga Kholmanskikh,Bellinda L. King-Kallimanis, Harlan Krumholz,Anna Minchom, Daniel O'Connor, Joan Petrie

EClinicalMedicine (2024): 102838-102838

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn